L. R. Brandao Et Al. , "Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children," BLOOD , vol.135, no.7, pp.491-504, 2020
Brandao, L. R. Et Al. 2020. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. BLOOD , vol.135, no.7 , 491-504.
Brandao, L. R., Albisetti, M., Halton, J., Bomgaars, L., Chalmers, E., Mitchell, L. G., ... Nurmeev, I.(2020). Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. BLOOD , vol.135, no.7, 491-504.
Brandao, ŞEVKİYE Et Al. "Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children," BLOOD , vol.135, no.7, 491-504, 2020
Brandao, ŞEVKİYE S. Et Al. "Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children." BLOOD , vol.135, no.7, pp.491-504, 2020
Brandao, L. R. Et Al. (2020) . "Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children." BLOOD , vol.135, no.7, pp.491-504.
@article{article, author={ŞEVKİYE SELİN AYTAÇ EYÜPOĞLU Et Al. }, title={Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children}, journal={BLOOD}, year=2020, pages={491-504} }